{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:20:37Z","timestamp":1788394837170,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470939"],"award-info":[{"award-number":["32470939"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170886"],"award-info":[{"award-number":["32170886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76201-3","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:43:32Z","timestamp":1785937412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RAS P21 Protein Activator 3 finetunes Type I immunity by limiting HCK-mediated STAT4 phosphorylation"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiayu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0207-9601","authenticated-orcid":false,"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-6007","authenticated-orcid":false,"given":"Jinfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-3850","authenticated-orcid":false,"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1656-3783","authenticated-orcid":false,"given":"Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"76201_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","volume":"135","author":"F Annunziato","year":"2015","unstructured":"Annunziato, F., Romagnani, C. & Romagnani, S. The 3 major types of innate and adaptive cell-mediated effector immunity. J. Allergy Clin. Immunol. 135, 626\u2013635 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"76201_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41423-022-00841-w","volume":"19","author":"X Zhao","year":"2022","unstructured":"Zhao, X. et al. MEF2C promotes M1 macrophage polarization and Th1 responses. Cell Mol. Immunol. 19, 540\u2013553 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"76201_CR3","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/s41418-022-01017-9","volume":"29","author":"YS Zhang","year":"2022","unstructured":"Zhang, Y. S. et al. Acetylation licenses Th1 cell polarization to constrain Listeria monocytogenes infection. Cell Death Differ. 29, 2303\u20132315 (2022).","journal-title":"Cell Death Differ."},{"key":"76201_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.1968","volume":"15","author":"C Yao","year":"2009","unstructured":"Yao, C. et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15, 633\u2013640 (2009).","journal-title":"Nat. Med."},{"key":"76201_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado4856","volume":"16","author":"YH Wang","year":"2024","unstructured":"Wang, Y. H. et al. IFN-gamma-producing T(H)1 cells and dysfunctional regulatory T cells contribute to the pathogenesis of Sjogren\u2019s disease. Sci. Transl. Med. 16, eado4856 (2024).","journal-title":"Sci. Transl. Med."},{"key":"76201_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri1132","volume":"3","author":"G Bouma","year":"2003","unstructured":"Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521\u2013533 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"76201_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.chom.2022.05.006","volume":"30","author":"SP Pandey","year":"2022","unstructured":"Pandey, S. P. et al. Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis. Cell Host Microbe. 30, 1003\u20131019 e1010 (2022).","journal-title":"Cell Host Microbe"},{"key":"76201_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","volume":"39","author":"X Yin","year":"2021","unstructured":"Yin, X., Chen, S. & Eisenbarth, S. C. Dendritic Cell Regulation of T Helper Cells. Annu. Rev. Immunol. 39, 759\u2013790 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"76201_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57603-1","volume":"16","author":"Z Wen","year":"2025","unstructured":"Wen, Z. et al. Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice. Nat. Commun. 16, 2362 (2025).","journal-title":"Nat. Commun."},{"key":"76201_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/ijms11030789","volume":"11","author":"T Hamza","year":"2010","unstructured":"Hamza, T., Barnett, J. B. & Li, B. Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J. Mol. Sci. 11, 789\u2013806 (2010).","journal-title":"Int J. Mol. Sci."},{"key":"76201_CR11","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1073\/pnas.182618999","volume":"99","author":"A Morinobu","year":"2002","unstructured":"Morinobu, A. et al. STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc. Natl. Acad. Sci. USA 99, 12281\u201312286 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76201_CR12","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1074\/jbc.274.4.1875","volume":"274","author":"LK Naeger","year":"1999","unstructured":"Naeger, L. K., McKinney, J., Salvekar, A. & Hoey, T. Identification of a STAT4 binding site in the interleukin-12 receptor required for signaling. J. Biol. Chem. 274, 1875\u20131878 (1999).","journal-title":"J. Biol. Chem."},{"key":"76201_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nri2958","volume":"11","author":"JJ O\u2019Shea","year":"2011","unstructured":"O\u2019Shea, J. J., Lahesmaa, R., Vahedi, G., Laurence, A. & Kanno, Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat. Rev. Immunol. 11, 239\u2013250 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"76201_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","volume":"100","author":"SJ Szabo","year":"2000","unstructured":"Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655\u2013669 (2000).","journal-title":"Cell"},{"key":"76201_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.immuni.2009.03.013","volume":"30","author":"EG Schulz","year":"2009","unstructured":"Schulz, E. G., Mariani, L., Radbruch, A. & Hofer, T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. Immunity 30, 673\u2013683 (2009).","journal-title":"Immunity"},{"key":"76201_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct. Target Ther. 6, 402 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"76201_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cytogfr.2012.06.005","volume":"23","author":"M Wieczorek","year":"2012","unstructured":"Wieczorek, M., Ginter, T., Brand, P., Heinzel, T. & Kramer, O. H. Acetylation modulates the STAT signaling code. Cytokine Growth Factor Rev. 23, 293\u2013305 (2012).","journal-title":"Cytokine Growth Factor Rev."},{"key":"76201_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14948-z","volume":"11","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. Nat. Commun. 11, 1146 (2020).","journal-title":"Nat. Commun."},{"key":"76201_CR19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.7150\/ijbs.41852","volume":"16","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. STAT4: an immunoregulator contributing to diverse human diseases. Int J. Biol. Sci. 16, 1575\u20131585 (2020).","journal-title":"Int J. Biol. Sci."},{"key":"76201_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa073003","volume":"357","author":"EF Remmers","year":"2007","unstructured":"Remmers, E. F. et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357, 977\u2013986 (2007).","journal-title":"N. Engl. J. Med."},{"key":"76201_CR21","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.cmet.2024.10.004","volume":"36","author":"V Gray","year":"2024","unstructured":"Gray, V. et al. Hyperglycemia-triggered lipid peroxidation destabilizes STAT4 and impairs anti-viral Th1 responses in type 2 diabetes. Cell Metab. 36, 2511\u20132527 e2517 (2024).","journal-title":"Cell Metab."},{"key":"76201_CR22","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1001\/jamadermatol.2023.3830","volume":"159","author":"J Martinez","year":"2023","unstructured":"Martinez, J. et al. Janus Kinase inhibitors and adverse events of acne: a systematic review and meta-analysis. JAMA Dermatol 159, 1339\u20131345 (2023).","journal-title":"JAMA Dermatol"},{"key":"76201_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","volume":"20","author":"A Virtanen","year":"2024","unstructured":"Virtanen, A. et al. JAK inhibitor selectivity: new opportunities, better drugs?. Nat. Rev. Rheumatol. 20, 649\u2013665 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"76201_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nri1461","volume":"4","author":"EG Pamer","year":"2004","unstructured":"Pamer, E. G. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4, 812\u2013823 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"76201_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/jid.2012.284","volume":"133","author":"T Honda","year":"2013","unstructured":"Honda, T., Egawa, G., Grabbe, S. & Kabashima, K. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J. Invest. Dermatol. 133, 303\u2013315 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"76201_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jbior.2014.09.006","volume":"57","author":"S Schurmans","year":"2015","unstructured":"Schurmans, S., Polizzi, S., Scoumanne, A., Sayyed, S. & Molina-Ortiz, P. The Ras\/Rap GTPase activating protein RASA3: from gene structure to in vivo functions. Adv. Biol. Regul. 57, 153\u2013161 (2015).","journal-title":"Adv. Biol. Regul."},{"key":"76201_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abl9169","volume":"15","author":"KH Johansen","year":"2022","unstructured":"Johansen, K. H. et al. A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cells. Sci. Signal 15, eabl9169 (2022).","journal-title":"Sci. Signal"},{"key":"76201_CR28","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2018.09.004","volume":"49","author":"B Wu","year":"2018","unstructured":"Wu, B. et al. RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs. Immunity 49, 886\u2013898 e885 (2018).","journal-title":"Immunity"},{"key":"76201_CR29","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1172\/JCI77993","volume":"125","author":"L Stefanini","year":"2015","unstructured":"Stefanini, L. et al. RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J. Clin. Invest. 125, 1419\u20131432 (2015).","journal-title":"J. Clin. Invest."},{"key":"76201_CR30","doi-asserted-by":"publisher","first-page":"12099","DOI":"10.1073\/pnas.1204948109","volume":"109","author":"L Blanc","year":"2012","unstructured":"Blanc, L. et al. Critical function for the Ras-GTPase activating protein RASA3 in vertebrate erythropoiesis and megakaryopoiesis. Proc. Natl. Acad. Sci. USA 109, 12099\u201312104 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76201_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S1471-4906(00)01815-9","volume":"22","author":"A Cavani","year":"2001","unstructured":"Cavani, A., Albanesi, C., Traidl, C., Sebastiani, S. & Girolomoni, G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol. 22, 118\u2013120 (2001).","journal-title":"Trends Immunol."},{"key":"76201_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1600-0536.2002.460101.x","volume":"46","author":"I Kimber","year":"2002","unstructured":"Kimber, I. & Dearman, R. J. Allergic contact dermatitis: the cellular effectors. Contact Dermat. 46, 1\u20135 (2002).","journal-title":"Contact Dermat."},{"key":"76201_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cmi.2011.11","volume":"8","author":"YG Zhao","year":"2011","unstructured":"Zhao, Y. G., Wang, Y., Hao, W. & Wan, Y. Y. An essential role for TAK1 in the contact hypersensitivity response. Cell Mol. Immunol. 8, 315\u2013324 (2011).","journal-title":"Cell Mol. Immunol."},{"key":"76201_CR34","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1111\/all.15314","volume":"77","author":"T Miyake","year":"2022","unstructured":"Miyake, T. et al. Circadian rhythm affects the magnitude of contact hypersensitivity response in mice. Allergy 77, 2748\u20132759 (2022).","journal-title":"Allergy"},{"key":"76201_CR35","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.immuni.2014.05.005","volume":"40","author":"SM Soudja","year":"2014","unstructured":"Soudja, S. M. et al. Memory-T-cell-derived interferon-gamma instructs potent innate cell activation for protective immunity. Immunity 40, 974\u2013988 (2014).","journal-title":"Immunity"},{"key":"76201_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.it.2016.04.001","volume":"37","author":"G Lauvau","year":"2016","unstructured":"Lauvau, G., Boutet, M., Williams, T. M., Chin, S. S. & Chorro, L. Memory CD8(+) T Cells: Innate-Like Sensors and Orchestrators of Protection. Trends Immunol. 37, 375\u2013385 (2016).","journal-title":"Trends Immunol."},{"key":"76201_CR37","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1073\/pnas.92.16.7307","volume":"92","author":"CM Bacon","year":"1995","unstructured":"Bacon, C. M. et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7307\u20137311 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76201_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40086-3","volume":"14","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy. Nat. Commun. 14, 4297 (2023).","journal-title":"Nat. Commun."},{"key":"76201_CR39","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41375-020-0934-6","volume":"35","author":"HC Lantermans","year":"2021","unstructured":"Lantermans, H. C. et al. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma. Leukemia 35, 881\u2013886 (2021).","journal-title":"Leukemia"},{"key":"76201_CR40","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1182\/blood-2009-04-218735","volume":"115","author":"C Cougoule","year":"2010","unstructured":"Cougoule, C. et al. Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis. Blood 115, 1444\u20131452 (2010).","journal-title":"Blood"},{"key":"76201_CR41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2422079122","volume":"122","author":"EK Nadendla","year":"2025","unstructured":"Nadendla, E. K. et al. HCK regulates NLRP12-mediated PANoptosis. Proc. Natl. Acad. Sci. USA 122, e2422079122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76201_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114339","volume":"160","author":"S Luo","year":"2023","unstructured":"Luo, S., Du, S., Tao, M., Cao, J. & Cheng, P. Insights on hematopoietic cell kinase: An oncogenic player in human cancer. Biomed. Pharmacother. 160, 114339 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"76201_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2147\/DDDT.S80207","volume":"9","author":"R Chen","year":"2015","unstructured":"Chen, R. & Chen, B. The role of dasatinib in the management of chronic myeloid leukemia. Drug Des. Dev. Ther. 9, 773\u2013779 (2015).","journal-title":"Drug Des. Dev. Ther."},{"key":"76201_CR44","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","volume":"34","author":"JE Cortes","year":"2016","unstructured":"Cortes, J. E. et al. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial. J. Clin. Oncol. 34, 2333\u20132340 (2016).","journal-title":"J. Clin. Oncol."},{"key":"76201_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ni1032","volume":"5","author":"N Ota","year":"2004","unstructured":"Ota, N., Brett, T. J., Murphy, T. L., Fremont, D. H. & Murphy, K. M. N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat. Immunol. 5, 208\u2013215 (2004).","journal-title":"Nat. Immunol."},{"key":"76201_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25700-6","volume":"12","author":"F Dang","year":"2021","unstructured":"Dang, F. et al. Inhibition of CK1epsilon potentiates the therapeutic efficacy of CDK4\/6 inhibitor in breast cancer. Nat. Commun. 12, 5386 (2021).","journal-title":"Nat. Commun."},{"key":"76201_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.molcel.2015.06.009","volume":"59","author":"RA Kamber","year":"2015","unstructured":"Kamber, R. A., Shoemaker, C. J. & Denic, V. Receptor-bound targets of selective autophagy use a scaffold protein to activate the Atg1 Kinase. Mol. Cell 59, 372\u2013381 (2015).","journal-title":"Mol. Cell"},{"key":"76201_CR48","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1182\/blood.V96.5.1844","volume":"96","author":"R Visconti","year":"2000","unstructured":"Visconti, R. et al. Importance of the MKK6\/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity. Blood 96, 1844\u20131852 (2000).","journal-title":"Blood"},{"key":"76201_CR49","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/385602a0","volume":"385","author":"F Sicheri","year":"1997","unstructured":"Sicheri, F., Moarefi, I. & Kuriyan, J. Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602\u2013609 (1997).","journal-title":"Nature"},{"key":"76201_CR50","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1097-2765(00)80357-3","volume":"3","author":"T Schindler","year":"1999","unstructured":"Schindler, T. et al. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3, 639\u2013648 (1999).","journal-title":"Mol. Cell"},{"key":"76201_CR51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.20020873","volume":"196","author":"M Ernst","year":"2002","unstructured":"Ernst, M. et al. Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J. Exp. Med. 196, 589\u2013604 (2002).","journal-title":"J. Exp. Med."},{"key":"76201_CR52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccell.2017.03.006","volume":"31","author":"AR Poh","year":"2017","unstructured":"Poh, A. R. et al. Inhibition of hematopoietic cell kinase activity suppresses myeloid cell-mediated colon cancer progression. Cancer Cell 31, 563\u2013575 e565 (2017).","journal-title":"Cancer Cell"},{"key":"76201_CR53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2408114121","volume":"121","author":"C Morin","year":"2024","unstructured":"Morin, C. et al. Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transition. Proc. Natl. Acad. Sci. USA 121, e2408114121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76201_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102170","volume":"51","author":"J Shi","year":"2025","unstructured":"Shi, J. et al. RPL36A activates ERK pathway and promotes colorectal cancer growth. Transl. Oncol. 51, 102170 (2025).","journal-title":"Transl. Oncol."},{"key":"76201_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.aan4526","volume":"358","author":"K Atarashi","year":"2017","unstructured":"Atarashi, K. et al. Ectopic colonization of oral bacteria in the intestine drives T(H)1 cell induction and inflammation. Science 358, 359\u2013365 (2017).","journal-title":"Science"},{"key":"76201_CR56","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1016\/j.apsb.2024.06.008","volume":"14","author":"L Yin","year":"2024","unstructured":"Yin, L. et al. Macrophage P2Y(6)R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses. Acta Pharm. Sin. B 14, 4360\u20134377 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"76201_CR57","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.1159806","volume":"321","author":"AM Intlekofer","year":"2008","unstructured":"Intlekofer, A. M. et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408\u2013411 (2008).","journal-title":"Science"},{"key":"76201_CR58","first-page":"277","volume":"4","author":"Z Ye","year":"2007","unstructured":"Ye, Z. et al. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation. Cell Mol. Immunol. 4, 277\u2013285 (2007).","journal-title":"Cell Mol. Immunol."},{"key":"76201_CR59","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ni1008-1091","volume":"9","author":"TS Heng","year":"2008","unstructured":"Heng, T. S., Painter, M. W. & Immunological Genome Project, C. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091\u20131094 (2008).","journal-title":"Nat. Immunol."},{"key":"76201_CR60","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41590-023-01483-4","volume":"24","author":"AJ Brenes","year":"2023","unstructured":"Brenes, A. J., Lamond, A. I. & Cantrell, D. A. The immunological proteome resource. Nat. Immunol. 24, 731 (2023).","journal-title":"Nat. Immunol."},{"key":"76201_CR61","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fimmu.2018.00714","volume":"9","author":"H Georgiev","year":"2018","unstructured":"Georgiev, H. et al. Shared and unique features distinguishing follicular t helper and regulatory cells of peripheral lymph node and Peyer\u2019s patches. Front Immunol. 9, 714 (2018).","journal-title":"Front Immunol."},{"key":"76201_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adr7057","volume":"10","author":"C Jager","year":"2025","unstructured":"Jager, C. et al. Inducible protein degradation reveals inflammation-dependent function of the T(reg) cell lineage-defining transcription factor Foxp3. Sci. Immunol. 10, eadr7057 (2025).","journal-title":"Sci. Immunol."},{"key":"76201_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1234747","volume":"14","author":"S Horitani","year":"2023","unstructured":"Horitani, S. et al. The critical role of Rap1-GAPs Rasa3 and Sipa1 in T cells for pulmonary transit and egress from the lymph nodes. Front. Immunol. 14, 1234747 (2023).","journal-title":"Front. Immunol."},{"key":"76201_CR64","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.it.2023.09.002","volume":"44","author":"KH Johansen","year":"2023","unstructured":"Johansen, K. H., Golec, D. P., Okkenhaug, K. & Schwartzberg, P. L. Mind the GAP: RASA2 and RASA3 GTPase-activating proteins as gatekeepers of T cell activation and adhesion. Trends Immunol. 44, 917\u2013931 (2023).","journal-title":"Trends Immunol."},{"key":"76201_CR65","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/13543784.2020.1800639","volume":"29","author":"L Calabrese","year":"2020","unstructured":"Calabrese, L. et al. Baricitinib: therapeutic potential for moderate to severe atopic dermatitis. Expert Opin. Investig. Drugs 29, 1089\u20131098 (2020).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"76201_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13075-024-03354-1","volume":"26","author":"K Makabe","year":"2024","unstructured":"Makabe, K. et al. Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6\/JAK\/STAT3 pathway and CSF-1 expression in dorsal root ganglion neurons. Arthritis Res. Ther. 26, 121 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"76201_CR67","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaad.2021.04.085","volume":"85","author":"K Papp","year":"2021","unstructured":"Papp, K. et al. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies. J. Am. Acad. Dermatol. 85, 863\u2013872 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"76201_CR68","doi-asserted-by":"publisher","unstructured":"Sechi, A. et al. Adverse events in patients treated with Jak-inhibitors for alopecia areata: A systematic review. J. Eur. Acad. Dermatol. Venereol. https:\/\/doi.org\/10.1111\/jdv.19090 (2023).","DOI":"10.1111\/jdv.19090"},{"key":"76201_CR69","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1182\/blood-2008-09-179820","volume":"113","author":"HC Chang","year":"2009","unstructured":"Chang, H. C. et al. Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood 113, 5887\u20135890 (2009).","journal-title":"Blood"},{"key":"76201_CR70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/382174a0","volume":"382","author":"MH Kaplan","year":"1996","unstructured":"Kaplan, M. H., Sun, Y. L., Hoey, T. & Grusby, M. J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174\u2013177 (1996).","journal-title":"Nature"},{"key":"76201_CR71","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1126\/science.1065543","volume":"295","author":"SJ Szabo","year":"2002","unstructured":"Szabo, S. J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338\u2013342 (2002).","journal-title":"Science"},{"key":"76201_CR72","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.4049\/jimmunol.168.4.1566","volume":"168","author":"Z Yin","year":"2002","unstructured":"Yin, Z. et al. T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells. J. Immunol. 168, 1566\u20131571 (2002).","journal-title":"J. Immunol."},{"key":"76201_CR73","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1182\/blood-2006-11-058271","volume":"110","author":"Y Yang","year":"2007","unstructured":"Yang, Y., Ochando, J. C., Bromberg, J. S. & Ding, Y. Identification of a distant T-bet enhancer responsive to IL-12\/Stat4 and IFNgamma\/Stat1 signals. Blood 110, 2494\u20132500 (2007).","journal-title":"Blood"},{"key":"76201_CR74","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.immuni.2008.08.017","volume":"29","author":"VT Thieu","year":"2008","unstructured":"Thieu, V. T. et al. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29, 679\u2013690 (2008).","journal-title":"Immunity"},{"key":"76201_CR75","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2022.03.005","volume":"55","author":"D Fang","year":"2022","unstructured":"Fang, D. et al. Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation. Immunity 55, 639\u2013655 e637 (2022).","journal-title":"Immunity"},{"key":"76201_CR76","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2012.09.007","volume":"37","author":"J Zhu","year":"2012","unstructured":"Zhu, J. et al. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37, 660\u2013673 (2012).","journal-title":"Immunity"},{"key":"76201_CR77","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2567.2008.03026.x","volume":"126","author":"TM Aune","year":"2009","unstructured":"Aune, T. M., Collins, P. L. & Chang, S. Epigenetics and T helper 1 differentiation. Immunology 126, 299\u2013305 (2009).","journal-title":"Immunology"},{"key":"76201_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/382171a0","volume":"382","author":"WE Thierfelder","year":"1996","unstructured":"Thierfelder, W. E. et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171\u2013174 (1996).","journal-title":"Nature"},{"key":"76201_CR79","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen, T. et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 50, D1522\u2013D1527 (2022).","journal-title":"Nucleic Acids Res."},{"key":"76201_CR80","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211\u2013D1217 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76201-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:03:07Z","timestamp":1788393787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76201"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76201-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9418"}}